Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 72

1.

A Public Health Strategy for the Opioid Crisis.

Saloner B, McGinty EE, Beletsky L, Bluthenthal R, Beyrer C, Botticelli M, Sherman SG.

Public Health Rep. 2018 Nov/Dec;133(1_suppl):24S-34S. doi: 10.1177/0033354918793627.

PMID:
30426871
2.

Closing the gaps in opioid use disorder research, policy and practice: conference proceedings.

Miclette MA, Leff JA, Cuan I, Samet JH, Saloner B, Mendell G, Bao Y, Ashburn MA, Bachhuber MA, Schackman BR, Polsky DE, Meisel ZF.

Addict Sci Clin Pract. 2018 Nov 13;13(1):22. doi: 10.1186/s13722-018-0123-3.

3.

Changes in primary care access at community health centers between 2012/2013 and 2016.

Saloner B, Wilk AS, Wissoker D, Candon M, Hempstead K, Rhodes KV, Polsky DE, Kenney GM.

Health Serv Res. 2018 Nov 5. doi: 10.1111/1475-6773.13082. [Epub ahead of print]

PMID:
30397918
4.

Commentary on Kertesz & Gordon (2019): Don't abandon opioid prescription control efforts, reform them.

Saloner B.

Addiction. 2019 Jan;114(1):181-182. doi: 10.1111/add.14422. Epub 2018 Sep 18. No abstract available.

PMID:
30225963
5.

Tobacco Screening and Counseling in the U.S.: Smokers With Mental Health and Substance Use Problems.

Samples H, Bandara S, Olfson M, Saloner B.

Am J Prev Med. 2018 Oct;55(4):524-532. doi: 10.1016/j.amepre.2018.05.024. Epub 2018 Aug 19.

PMID:
30135038
6.

Is screening and intervention associated with treatment receipt among individuals with alcohol use disorder? Evidence from a national survey.

Bandara SN, Samples H, Crum RM, Saloner B.

J Subst Abuse Treat. 2018 Sep;92:85-90. doi: 10.1016/j.jsat.2018.06.009. Epub 2018 Jun 22.

PMID:
30032949
7.

Moving Addiction Care to the Mainstream - Improving the Quality of Buprenorphine Treatment.

Saloner B, Stoller KB, Alexander GC.

N Engl J Med. 2018 Jul 5;379(1):4-6. doi: 10.1056/NEJMp1804059. No abstract available.

PMID:
29972745
8.

Buprenorphine Use and Spending for Opioid Use Disorder Treatment: Trends From 2003 to 2015.

Roberts AW, Saloner B, Dusetzina SB.

Psychiatr Serv. 2018 Jul 1;69(7):832-835. doi: 10.1176/appi.ps.201700315. Epub 2018 May 8.

9.

Physician Time Burden Associated with Querying Prescription Drug Monitoring Programs.

Bachhuber MA, Saloner B, LaRochelle M, Merlin JS, Maughan BC, Polsky D, Shaparin N, Murphy SM.

Pain Med. 2018 Oct 1;19(10):1952-1960. doi: 10.1093/pm/pny053.

PMID:
29618105
10.

Most Primary Care Physicians Provide Appointments, But Affordability Remains A Barrier For The Uninsured.

Saloner B, Hempstead K, Rhodes K, Polsky D, Pan C, Kenney GM.

Health Aff (Millwood). 2018 Apr;37(4):627-634. doi: 10.1377/hlthaff.2017.0959.

PMID:
29608344
11.

Medicaid Expansion, Chronic Disease, and the Next Chapter of Health Reform.

Saloner B.

J Gen Intern Med. 2018 Mar;33(3):243-244. doi: 10.1007/s11606-017-4262-0. No abstract available.

PMID:
29273894
12.

Only One In Twenty Justice-Referred Adults In Specialty Treatment For Opioid Use Receive Methadone Or Buprenorphine.

Krawczyk N, Picher CE, Feder KA, Saloner B.

Health Aff (Millwood). 2017 Dec;36(12):2046-2053. doi: 10.1377/hlthaff.2017.0890.

13.

Medicaid Coverage of Methadone Maintenance and the Use of Opioid Agonist Therapy Among Pregnant Women in Specialty Treatment.

Bachhuber MA, Mehta PK, Faherty LJ, Saloner B.

Med Care. 2017 Dec;55(12):985-990. doi: 10.1097/MLR.0000000000000803.

14.

Declining Medicaid Fees and Primary Care Appointment Availability for New Medicaid Patients.

Candon M, Zuckerman S, Wissoker D, Saloner B, Kenney GM, Rhodes K, Polsky D.

JAMA Intern Med. 2018 Jan 1;178(1):145-146. doi: 10.1001/jamainternmed.2017.6302. No abstract available.

15.

Changes in spending and service use after a state autism insurance mandate.

Saloner B, Barry CL.

Autism. 2017 Nov 1:1362361317728205. doi: 10.1177/1362361317728205. [Epub ahead of print]

PMID:
29126371
16.

The response of substance use disorder treatment providers to changes in macroeconomic conditions.

Cantor J, Stoller KB, Saloner B.

J Subst Abuse Treat. 2017 Oct;81:59-65. doi: 10.1016/j.jsat.2017.07.005. Epub 2017 Jul 8.

PMID:
28847456
17.

Racial and ethnic differences in opioid agonist treatment for opioid use disorder in a U.S. national sample.

Krawczyk N, Feder KA, Fingerhood MI, Saloner B.

Drug Alcohol Depend. 2017 Sep 1;178:512-518. doi: 10.1016/j.drugalcdep.2017.06.009. Epub 2017 Jul 11.

18.

Pregnant Immigrants: The Authors Reply.

Wherry LR, Saloner B.

Health Aff (Millwood). 2017 Jul 1;36(7):1346. doi: 10.1377/hlthaff.2017.0664. No abstract available.

PMID:
28679825
19.

Closing the Medication-Assisted Treatment Gap for Youth With Opioid Use Disorder.

Saloner B, Feder KA, Krawczyk N.

JAMA Pediatr. 2017 Aug 1;171(8):729-731. doi: 10.1001/jamapediatrics.2017.1269. No abstract available.

20.

Medical Financial Burden Declined For Consumers In The Nongroup Market.

Boudreaux MH, Gonzales G, Saloner B.

Health Aff (Millwood). 2017 May 1;36(5):833-837. doi: 10.1377/hlthaff.2016.1480.

PMID:
28461349

Supplemental Content

Loading ...
Support Center